关注
Junjie Li
Junjie Li
Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School
在 bidmc.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
CuS nanodots with ultrahigh efficient renal clearance for positron emission tomography imaging and image-guided photothermal therapy
M Zhou, J Li, S Liang, AK Sood, D Liang, C Li
ACS nano 9 (7), 7085-7096, 2015
3152015
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors
G La Regina, R Bai, WM Rensen, E Di Cesare, A Coluccia, F Piscitelli, ...
Journal of medicinal chemistry 56 (1), 123-149, 2013
1082013
A dual-targeting anticancer approach: soil and seed principle
J Li, Z Sun, J Zhang, H Shao, M Miranda Cona, H Wang, T Marysael, ...
Radiology 260 (3), 799-807, 2011
942011
A review on various targeted anticancer therapies
J Li, F Chen, MM Cona, Y Feng, U Himmelreich, R Oyen, A Verbruggen, ...
Targeted oncology 7, 69-85, 2012
932012
Research perspectives: gold nanoparticles in cancer theranostics
J Li, S Gupta, C Li
Quantitative Imaging in Medicine and Surgery 3 (6), 284-291, 2013
712013
Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours
H Wang, J Li, F Chen, F De Keyzer, J Yu, Y Feng, J Nuyts, G Marchal, Y Ni
European radiology 20, 2013-2026, 2010
582010
Diffusion‐weighted MRI of hepatic tumor in rats: Comparison between in vivo and postmortem imaging acquisitions
X Sun, H Wang, F Chen, F De Keyzer, J Yu, Y Jiang, Y Feng, J Li, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009
542009
Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models
J Li, MM Cona, F Chen, Y Feng, L Zhou, J Yu, J Nuyts, P de Witte, J Zhang, ...
Theranostics 2 (10), 1010-1019, 2012
532012
Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID …
J Li, MM Cona, F Chen, Y Feng, L Zhou, G Zhang, J Nuyts, P de Witte, ...
Theranostics 3 (2), 127-137, 2013
502013
Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential
M Van de Putte, T Marysael, H Fonge, T Roskams, MM Cona, J Li, ...
International Journal of Cancer 131 (2), E129-E137, 2012
482012
Tumor models and specific contrast agents for small animal imaging in oncology
Y Ni, H Wang, F Chen, J Li, F DeKeyzer, Y Feng, J Yu, H Bosmans, ...
Methods 48 (2), 125-138, 2009
432009
Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
J Li, F Liu, S Gupta, C Li
Theranostics, 2016
402016
Hepatocellular Carcinoma: Intraarterial Delivery of Doxorubicin loaded Hollow Gold Nanospheres for Photothermal Ablation— Chemoembolization Therapy in Rats
J Li, M Zhou, F Liu, C Xiong, W Wang, Q Cao, X Wen, D Robertson, X Ji, ...
Radiology, 2016
362016
Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology
X Wu, H Wang, F Chen, L Jin, J Li, Y Feng, F DeKeyzer, J Yu, G Marchal, ...
Acta radiologica 50 (3), 276-287, 2009
352009
Development and evaluation of a 68Ga labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography
K Prinsen, J Li, H Vanbilloen, P Vermaelen, E Devos, L Mortelmans, ...
Bioorganic & medicinal chemistry 18 (14), 5274-5281, 2010
332010
Assessing the pentose phosphate pathway using [2, 3‐13C2]glucose
MH Lee, CR Malloy, IR Corbin, J Li, ES Jin
NMR in Biomedicine 32 (6), e4096, 2019
312019
Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy
RA Sheth, X Wen, J Li, MP Melancon, X Ji, Y Andrew Wang, CH Hsiao, ...
Cancer nanotechnology 11, 1-16, 2020
262020
Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRI
F Chen, Y Feng, K Zheng, F De Keyzer, J Li, Y Feng, MM Cona, H Wang, ...
PLoS One 7 (7), e41140, 2012
242012
Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation
NY Cona MM, Alpizar YA, Li J, Bauwens M, Feng Y, Sun
Pharmaceutical Research 31 (2), 278-90, 2014
222014
Small molecule sequential dual-targeting theragnostic strategy (SMSDTTS): from preclinical experiments towards possible clinical anticancer applications
J Li, R Oyen, A Verbruggen, Y Ni
Journal of Cancer 4 (2), 133, 2013
222013
系统目前无法执行此操作,请稍后再试。
文章 1–20